Home › Funds › CANNELL CAPITAL LLC › ETON
CANNELL CAPITAL LLC position in ETON
ETON PHARMACEUTICALS INC COM · Health Care
CANNELL CAPITAL LLC reported holding 170,747 shares of ETON (ETON PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 4.37% of its reported portfolio and ranking #10 among its reported holdings. CANNELL CAPITAL LLC has disclosed ETON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How CANNELL CAPITAL LLC's ETON position evolved
CANNELL CAPITAL LLC first disclosed a stake in ETON in Q4 2024 at 381,323 shares (US$5.1M). The position peaked in Q3 2025 at 455,405 shares, worth US$9.9M. Across 7 filings, CANNELL CAPITAL LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 170,747 shares valued at US$6.2M — a reduction of -171,238 shares quarter over quarter.. Notable position changes include a 81% increase in Q1 2025 (shares rose 10% over the following quarter), a 52% trim in Q4 2025 (shares rose 46% over the following quarter), a 58% increase in Q1 2026 (shares rose 47% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 381.32K | $5.08M | New |
| Q1 2025 | 691.37K | $8.97M | Add |
| Q2 2025 | 388.18K | $5.53M | Reduce |
| Q3 2025 | 455.40K | $9.90M | Add |
| Q4 2025 | 216.92K | $3.67M | Reduce |
| Q1 2026 | 341.99K | $8.44M | Add |
| Q2 2026 | 170.75K | $6.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC COM) is a Health Care company. 64 other funds we track also report a position in ETON — the largest reported positions include Opaleye Management Inc. (US$103.5M), EcoR1 Capital, LLC (US$78.6M), Nantahala Capital Management, LLC (US$42.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- EcoR1 Capital, LLC 2.17M sh · $78.62M · Q2 2026
- Nantahala Capital Management, LLC 1.18M sh · $42.57M · Q2 2026
- National Philanthropic Trust 492.11K sh · $17.81M · Q2 2026
- Westside Investment Management, Inc. 431.16K sh · $15.61M · Q2 2026
- Pillsbury Lake Capital LLC 387.16K sh · $14.02M · Q2 2026
- Panoramic Capital, LLC 208.19K sh · $7.54M · Q2 2026
- Lumbard & Kellner, LLC 175.91K sh · $6.37M · Q2 2026
- Prospect Capital Advisors, LLC 157.20K sh · $5.69M · Q2 2026
- Aristides Capital LLC 145.41K sh · $5.26M · Q2 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 137.57K sh · $4.98M · Q2 2026
More on CANNELL CAPITAL LLC
FAQ
How long has CANNELL CAPITAL LLC held ETON?
CANNELL CAPITAL LLC has disclosed ETON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is CANNELL CAPITAL LLC's current position in ETON?
As of Q2 2026, CANNELL CAPITAL LLC holds 170.75K shares of ETON (ETON PHARMACEUTICALS INC COM), valued at $6.18M, representing 4.37% of its reported portfolio and ranking #10.
Has CANNELL CAPITAL LLC been buying or selling ETON?
In the latest 13F filing (Q2 2026), CANNELL CAPITAL LLC reduced its position in ETON. The position peaked in Q3 2025 at 455.40K shares.
Which other funds hold ETON?
Other major institutional holders of ETON include Opaleye Management Inc., EcoR1 Capital, LLC, Nantahala Capital Management, LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.